Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹865.00.
29 Oct: open ₹868.30, high ₹897.40, low ₹860.20
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,350 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 44,68549.6% delivered
Orchid Pharma board meetings
137 filed, newest first. Page 1 of 3.
Oct 2026
20 Oct · Board meeting
15 Oct · Board meeting
Sep 2026
3 Sep · Board meeting
Aug 2026
1 Aug · Board meeting
Jul 2026
28 Jul · Board meeting
10 Jul · Board meeting
May 2026
19 May · Board meeting
Feb 2026
11 Feb · Board meeting
Nov 2025
Aug 2025
5 Aug · Board meeting
May 2025
26 May · Board meeting
Feb 2025
Nov 2024
11 Nov · Board meeting
Aug 2024
12 Aug · Board meeting
6 Aug · Board meeting
Jul 2024
19 Jul · Board meeting
17 Jul · Board meeting
May 2024
23 May · Board meeting
16 May · Board meeting
Feb 2024
8 Feb · Board meeting
8 Feb · Board meeting
Oct 2023
28 Oct · Board meeting
Aug 2023
Jun 2023
27 Jun · Board meeting
27 Jun · Board meeting
27 Jun · Board meeting
22 Jun · Board meeting
May 2023
3 May · Board meeting
Feb 2023
Dec 2022
1 Dec · Board meeting
Nov 2022
28 Nov · Board meeting
Aug 2022
May 2022
Feb 2022
12 Feb · Board meeting
Dec 2021
Nov 2021
14 Nov · Board meeting
Aug 2021
13 Aug · Board meeting